NCT00004212View on ClinicalTrials.gov

DX-8951f in Treating Children With Advanced Solid Tumors or Lymphomas

PHASE1CompletedINTERVENTIONAL
Timeline

Start Date

September 30, 1999

Primary Completion Date

April 30, 2004

Study Completion Date

April 30, 2004

Conditions
Brain and Central Nervous System TumorsLymphomaUnspecified Childhood Solid Tumor, Protocol Specific
Interventions
BIOLOGICAL

filgrastim

DRUG

exatecan mesylate

Trial Locations (4)

10021

Memorial Sloan-Kettering Cancer Center, New York

75235

Children's Medical Center of Dallas, Dallas

38105-2794

St. Jude Children's Research Hospital, Memphis

78245-3217

Institute for Drug Development, San Antonio

Sponsors

Lead Sponsor

Daiichi Sankyo
All Listed Sponsors
lead

Daiichi Sankyo

INDUSTRY